NCT02877069View on ClinicalTrials.gov

Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

October 31, 2016

Conditions
Skin Roughness
Interventions
DEVICE

VYC-12 HA injectable gel

VYC-12 Hyaluronic Acid (HA) injectable gel administered as an intradermal injection.

Trial Locations (1)

69 100

Laboratoire Dermscan-Pharmascan, Lyon

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY